EFA-Live: State of health in the EU & digitalization of health promotion
On January 22nd, EFA attended a policy discussion on “the state of health in the EU and the digitalisation of health”, organized by the Brussels based think tank Bruegel. As the European Commission  ...

Read more

EFA-Live: EFA’s new Roadmap – #ShowLeadership in 2020
Show you care about patients, show leadership! This is how the allergy, asthma and COPD patient community kick-starts the new decade. With a new roadmap and full of energy, EFA continues advocating to ...

Read more

A Roadmap to patient safety, access to healthcare and eradicating inequalities
In connection with the #ShowLeadership campaign and our recently published ACCESS report, EFA organised an event in the Strasbourg European Parliament, hosted by Member of the European Parliament (MEP ...

Read more

EFA continues to #ShowLeadership for people living with allergies, asthma and COPD
In 2019, EFA launched the #ShowLeadership campaign to encourage relevant stakeholders – including patients and caregivers, healthcare professionals and policymakers – to take action and address the ch ...

Read more

Interest Group on Asthma and Allergy is launched! A new Direction for Allergy and Asthma health in Europe
On November 26th, the European Parliament Interest Group on Allergy and Asthma had its first policy meeting of the current 2019 -2024 mandate, organised by EAACI in collaboration with EFA. The event,  ...

Read more

EFA at EMA Patients and Healthcare Professionals Meeting
On 20 November, EFA attended the Annual European Medicines Agency meeting with all eligible organisations who are members of the EMA Patient and Consumer- and Healthcare professionals working parties  ...

Read more

EFA contributes to EPIS Summit
Digital solutions have the potential to improve the life of millions of European patients and transform the way we deliver care at country level. However, the uptake of digital solutions is still low  ...

Read more

Moving forward to better management and personalised therapy in asthma and COPD
However, recent studies have shown that on a molecular level, certain patterns are shared by patients, suggesting that they may also share pathways of response to treatment and disease progression.  ...

Read more

EFA launches European report "Active Patients Access Care"
EFA eagerly launches its new European report “Active Asthma and COPD Patients ACCESS Care”. The report unveils new patient evidence on asthma and COPD patients’ access to diagnosis and care, involveme ...

Read more

EFA launches new European report “Active Patients ACCESS Care”
EFA eagerly launches its new European report “Active Asthma and COPD Patients ACCESS Care”. The report unveils new patient evidence on asthma and COPD patients’ access to diagnosis and care, involveme ...

Read more

EFA at European Health Stakeholder Meeting in the European Parliament
On September 12th, EFA participated in a panel-discussion in the European Parliament on “Brexit: the European Parliaments’ role in prioritising patients, public health and health security across Europ ...

Read more

CURE project shows good mid-term results
Despite great advances in research, unfortunately, there is still no cure for asthma. The CURE project, funded by the EU, is looking at possible innovative solutions, such as bacteriophages, a type of ...

Read more

EFA Response to EMA Public Consultation on Patient Registries
The European Medicines Agency (EMA) launched a public consultation on the basis of a discussion paper focusing on the “use of patient disease registries for regulatory purposes – methodological and op ...

Read more

EFA at EFPIA Annual Conference
EFA Director Susanna Palkonen attended the annual networking event of the European Federation of Pharmaceutical Industries Associations (EFPIA). The event was hosted by the Finnish EU Presidency. Ec ...

Read more

United Nations: Tobacco Control as Human Rights and Ministerial meeting on sustainable development
In light of the 41st session of the United Nations (UN) Human Rights Council which took place from June 14th to July 12th in Geneva, Switzerland, the Secretariat of the World Health Organisation (WHO) ...

Read more

MyAirCoach presented at key medicines conference
On Friday 14th June, EFA was invited to speak at the Annual Medicines Europe and International Generic and Biosimilar Medicines Association Conference in Warsaw, Poland. The conference focussed on ‘ho ...

Read more

We spoke about adrenaline auto-injectors at the 2019 EAACI 2019 Congress
EFA participated in the European Academy of Allergy and Clinical Immunology (EAACI) Congress, celebrated in Lisbon from 1st to 5th June. The Congress is the biggest world allergy forum in the world, a ...

Read more

Apply to participate in the IMI pool of patient experts
The Innovative Medicine Initiative (IMI) is a public-private partnership between the European Union and the European pharmaceutical industry. It is working to improve health by speeding up the develop ...

Read more

World Asthma Day: European grassroots initiatives to connect with the asthma community
On May 7th, airways diseases patients celebrated World Asthma Day all over the globe to raise awareness for the disease. In Europe, EFA communicated about current problems related to access to diagnos ...

Read more

Event report of the European Parliament Interest Group on Allergy and Asthma published
On 20th March, the European Parliament Interest Group on Allergy and Asthma, co-run by EFA and EAACI, organised at the European Parliament a Breakfast Policy Meeting on a renewed EU policy agenda on a ...

Read more

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team